Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CVM
#4815
Cel-Sci Corporation Common Stock
1.1
4
USD
-0.07%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-7.32%
Monthly Change
+11.76%
6 month change
-77.86%
Year Change
-77.86%
Previous Close
1.2
3
Open
1.1
5
Low
1.1
4
High
1.1
5
Volume
33
Markets
US Stock Market
Healthcare
Biotechnology
CVM
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Q2, 26
Current
Key stats
Total common shares outstanding
2.57 M
3.03 M
6.88 M
8.41 M
8.46 M
8.49 M
8.49 M
Valuation ratios
Enterprise value
30.88 M
20.97 M
15.76 M
77.36 M
44.49 M
27.26 M
12 M
Price to earnings ratio
—
—
-0.23
-1.47
-1.42
-1.57
-0.69
Price to sales ratio
—
—
—
-57.5
-35.7
-32.58
-14.34
Price to cash flow ratio
—
—
-0.32
-2.18
-1.27
-1.04
-0.46
Price to book ratio
—
—
0.14
2.34
0.53
0.41
0.18
Enterprise value to EBITDA ratio
-1.13
-0.77
-0.61
-3.31
-1.87
-1.2
-0.53
Profitability ratios
Return on assets %
-0.28
-0.3
-0.28
-0.22
-0.24
-0.31
-0.31
Return on equity %
-0.63
-0.82
-0.81
-0.38
-0.49
-0.8
-0.8
Return on invested capital %
—
—
—
—
—
—
—
Gross margin %
100
100
100
100
100
100
100
Operating margin %
4 052.5
3 586.43
3 190.28
4 695.02
6 115.58
4 533.35
4 533.35
EBITDA margin %
4 147.79
3 682.5
3 286.22
4 774.01
6 209.88
4 628.25
4 628.25
Net margin %
4 158.11
3 686.43
3 292.48
4 747.6
6 230.22
4 652.3
4 652.3
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
1.07
0.55
0.47
2.26
1.39
0.6
0.6
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
-0.01
-0.01
-0.01
-0.01
-0
-0.01
-0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-1.9
-1.55
-0.95
-1.15
-0.5
-0.49
-3.1
EBIT per share
-3.24
-2.33
-1.36
-1.52
-0.68
-0.67
-4.23
EBITDA per share
-3.24
-2.33
-1.36
-1.51
-0.68
-0.67
-4.22
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
—
Net current asset value per share
2.69
1.07
0.63
2.86
0.88
0.36
0.36
Tangible book value per share
5.19
2.84
1.69
3.93
1.39
0.84
0.84
Working capital per share
0.17
-0.88
-0.72
1.59
0.25
-0.24
-0.24
Book value per share
5.19
2.84
1.69
3.93
1.39
0.84
0.84
News
Kersten Geert buys Cel Sci (CVM) shares worth $200000
Cel-Sci revises shareholder rights agreement following board approval
CEL-SCI stock falls after pricing $10M public offering at discount
CEL-SCI raises $5.7 million in at-market offering of common stock
CEL-SCI prices $5.7 million common stock offering at $3.82 per share
CEL-SCI stock soars after Saudi partnership for cancer drug Multikine
CEL-SCI partners with Saudi pharmaceutical firm to bring Multikine to market
CEL-SCI applauds FDA approval of Merck’s Keytruda for head and neck cancer
CVM stock touches 52-week low at $2.32 amid sharp annual decline
CEL-SCI Announces Closing of Public Offering
CEL-SCI Announces Pricing of Public Offering
CEL-SCI announces public stock offering to fund cancer therapy